Edition:
United Kingdom

OncoMed Pharmaceuticals Inc (OMED.OQ)

OMED.OQ on NASDAQ Stock Exchange Global Select Market

2.81USD
8:09pm BST
Change (% chg)

$0.02 (+0.72%)
Prev Close
$2.79
Open
$2.81
Day's High
$2.84
Day's Low
$2.70
Volume
5,828
Avg. Vol
12,055
52-wk High
$5.55
52-wk Low
$1.75

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 6.87 -0.104
Mar '18 7.85 -0.146
FY 2017 Dec '17 20.64 0.220
Sep '17 5.11 -0.284
Jun '17 6.20 -0.405
Mar '17 6.21 -0.607
FY 2016 Dec '16 6.22 -0.602
Sep '16 5.92 -0.766
Jun '16 6.66 -0.914
Mar '16 6.35 -0.900
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 3 7.38 9.43 6.20 5.61
Quarter Ending Dec-18 3 7.16 9.27 6.00 5.61
Year Ending Dec-18 3 29.24 33.41 27.10 31.03
Year Ending Dec-19 3 26.69 30.00 25.00 44.20
Earnings (per share)
Quarter Ending Sep-18 3 -0.20 -0.10 -0.37 -0.39
Quarter Ending Dec-18 3 -0.19 -0.09 -0.36 -0.38
Year Ending Dec-18 3 -0.73 -0.44 -1.25 -1.51
Year Ending Dec-19 3 -0.83 -0.42 -1.50 -0.92
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.68 32.76
P/E High - Last 5 Yrs. -- 300.70 45.44
P/E Low - Last 5 Yrs. -- 92.08 24.26
Beta 2.74 0.93 0.89
Price to Sales (TTM) 6.68 114.98 5.75
Price to Book (MRQ) -- 15.51 5.00
Price to Tangible Book (MRQ) -- 14.62 6.57
Price to Cash Flow (TTM) -- 72.88 23.29
% Owned Institutions 73.35 14.70 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.36 1.51
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.72 5.22
Payout Ratio(TTM) -- 16.50 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -7.07 411.54 8.01
Sales (TTM) vs TTM 1 Yr. Ago 0.01 80.36 5.64
Sales - 5 Yr. Growth Rate -4.35 32.26 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago 48.37 29.14 20.61
EPS (TTM) vs TTM 1 Yr. Ago 28.37 -- --
EPS - 5 Yr. Growth Rate -- 39.84 10.66
Capital Spending - 5 Yr. Growth Rate -12.42 40.42 15.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.91 2.22
Current Ratio (MRQ) 3.39 5.46 3.03
LT Debt to Equity (MRQ) -- 35.27 12.51
Total Debt to Equity (MRQ) -- 37.09 16.85
Interest Coverage (TTM) -- -102.34 32.65

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 39.18 54.37
Gross Margin - 5 Yr. Avg. -- 50.58 52.17
EBITD Margin (TTM) -335.43 -- --
EBITD - 5 Yr. Avg -181.75 -600.62 10.68
Operating Margin (TTM) -352.49 -759.72 4.32
Operating Margin - 5 Yr. Avg. -186.73 -621.66 6.11
Pre-Tax Margin (TTM) -350.45 -733.57 5.18
Pre-Tax Margin - 5 Yr. Avg. -186.42 -627.35 6.51
Net Profit Margin (TTM) -350.52 -734.95 1.48
Net Profit Margin - 5 Yr. Avg. -187.38 -630.40 2.78
Effective Tax Rate (TTM) -- 23.33 23.11
Effective Tax Rate - 5 Yr. Avg. -- 18.66 23.97

Efficiency

  Company industry sector
Revenue/Employee (TTM) 201,188 23,229,177 860,372,597
Net Income/Employee (TTM) -705,205 3,144,172 101,206,889
Receivable Turnover (TTM) 12.24 20.89 5.87
Inventory Turnover (TTM) -- 2.46 3.41
Asset Turnover (TTM) 0.15 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -53.56 -0.15 11.13
Return on Assets - 5 Yr. Avg. -27.30 3.51 12.40
Return on Investment (TTM) -75.79 1.78 14.61
Return on Investment - 5 Yr. Avg. -34.15 2.56 16.13
Return on Equity (TTM) -- 3.29 16.33
Return on Equity - 5 Yr. Avg. -- 3.43 17.39
  1 Year 3 Year 5 Year
Sales % -2.88 -12.68 -4.35
EPS (TTM) % -10.32 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for OncoMed Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -3.11 -6.45 29 52
13 Week 27.49 21.28 80 66
26 Week -50.23 -54.01 10 80
52 Week -61.28 -67.18 12 50
YTD -43.45 -50.34 14 61
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 65.34%
# of Holders: 82
Total Shares Held: 25,156,437
3 Mo. Net Change: -164,434
# New Positions: 8
# Closed Positions: 9
# Increased Positions: 32
# Reduced Positions: 27
# Net Buyers: 5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.